TVGN · Tevogen Bio Holdings Inc.
$5.04
+0.90 (+21.59%)
At close · Jul 27
Market Cap
$18.80M
Shares
4.19M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.41
Open$3.95
Day$3.82–4.41
52W$3.64–70.00
Avg vol 30d21K
Short int65K · 1.5% float · 3.9d
Short vol75%
DataJan 2022–Jul 2026
Filing10-Q · May 15
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−69%
below
Price vs 50-day avg
−43%
below
RSI (14)
34
neutral
MACD trend
Negative
52-week position
1%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−55%
trailing
6-month return
−71%
trailing
YTD return
−73%
this year
Relative strength
−77%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $8 › 200d $14 — 200d above 50d
Institutional flow
Distributing
8 of 27 funds reported for Jun 30 · net -163 sh shares · +5 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.55% of float · ▼ -0.8% MoM · 3.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
27 holders — mid 2-yr range
Squeeze score
50
elevated · 0–100
Fundamentals
EPS growth
−131%
Y/Y
Free cash flow
$-12.4M
Balance sheet
$0
net cash
Quant / Vol
risk profile
Volatility
111%
annualized · 1-yr
Max drawdown
−93%
past year
ATR
17.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−69%
Bearish
Price vs 50-day avg
−43%
Bearish
RSI (14)
34
Neutral
MACD trend
Negative
Bearish
52-week position
1%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $8 › 200d $14 — 200d above 50d
Institutional flow
Distributing
8 of 27 funds reported for Jun 30 · net -163 sh shares · +5 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.55% of float · ▼ -0.8% MoM · 3.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
27 holders — mid 2-yr range
Price context
position in its 52-week range
52-wk low $4
Now $4 · 1%
52-wk high $70
vs 200-day avg -69%
vs 50-day avg -43%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TVGN
this stock
Tevogen Bio Holdings Inc.
|
$18.80M | -73.4% | — | — | 1.5% |
|
ONC
BeOne Medicines Ltd.
|
$471.01B | +7.6% | +22179.2% | 958.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.16B | +4.4% | +46.2% | 28.3 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.78B | -15.4% | +20.8% | 16.0 | 3.3% |
|
ARGX
Argenx SE
|
$57.44B | +9.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TVGN | +0.0% | -55.1% | -70.5% | -22.1% | -73.4% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | +1.7% | -55.8% | -76.9% | -20.9% | -81.6% |